ARIAD Pharma (ARIA) on Watch After Filing Form 10-Q

November 8, 2016 5:40 PM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

ARIAD Pharma (NASDAQ: ARIA) was on watch after filing form 10-Q with the SEC:

From the filing:

In October 2016, we received a letter from Rep. Elijah Cummings and Sen. Bernard Sanders requesting information and supporting documentation from us related to Iclusig and the pricing of Iclusig in the United States since 2012. The letter inquired about our approach to pricing, commercialization and related matters for Iclusig. We responded to the letter on November 4, 2016 and are cooperating with this inquiry.

In November 2016, we received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts requesting documents related to our support of 501(c)(3) organizations that provide financial assistance to Medicare patients and our patient support programs. Other companies in our industry have disclosed similar inquiries. We intend to cooperate with this inquiry.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Litigation

Add Your Comment